Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04405869
Study type Observational
Source University Hospital, Strasbourg, France
Contact Charles TACQUARD, MD
Phone 33 3 69 55 16 08
Email charlesambroise.tacquard@chru-strasbourg.fr
Status Recruiting
Phase
Start date April 29, 2020
Completion date April 2021

See also
  Status Clinical Trial Phase
Completed NCT01580085 - Obstructive Sleep Apnea in Pulmonary Embolism N/A
Enrolling by invitation NCT01558206 - Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE N/A
Completed NCT01513759 - Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy Phase 3
Completed NCT02616991 - Computed Tomography CT Venography During Postpartum Venous Thromboembolism N/A
Completed NCT00968929 - Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) Phase 4
Not yet recruiting NCT06206967 - Promotion of Active Lifestyle in Thromboembolism Patients N/A
Completed NCT03595891 - The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung
Completed NCT01206751 - Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation N/A